Graham Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
+24,859
| New | +$1.07M | 0.02% | 525 |
|
|
2025
Q1 | – | Sell |
-4,725
| Closed | -$130K | – | 1258 |
|
|
2024
Q4 | $130K | Sell |
4,725
-27,696
| -85% | -$760K | ﹤0.01% | 1106 |
|
|
2024
Q3 | $825K | Buy |
32,421
+15,712
| +94% | +$400K | 0.01% | 477 |
|
|
2024
Q2 | $423K | Buy |
+16,709
| New | +$423K | 0.01% | 607 |
|
|
2024
Q1 | – | Sell |
-1,079
| Closed | -$43.6K | – | 1039 |
|
|
2023
Q4 | $43.6K | Buy |
+1,079
| New | +$43.6K | ﹤0.01% | 921 |
|
|
2022
Q4 | – | Sell |
-603,126
| Closed | -$6M | – | 1043 |
|
|
2022
Q3 | $6M | Buy |
603,126
+172,855
| +40% | +$1.72M | 0.24% | 41 |
|
|
2022
Q2 | $3.91M | Sell |
430,271
-113,941
| -21% | -$1.03M | 0.16% | 75 |
|
|
2022
Q1 | $5.52M | Buy |
+544,212
| New | +$5.52M | 0.19% | 52 |
|